Selecting patients for epilepsy surgery: Synthesis of data |
| |
| Authors: | John S. Duncan |
| |
| Affiliation: | 1. Institute for Drug Research, School of Pharmacy, The Hebrew University of Jerusalem, Jerusalem, Israel;2. Casali Institute of Applied Chemistry, Institute of Chemistry and Center for Nanoscience and Nanotechnology, The Hebrew University of Jerusalem, Jerusalem, Israel;3. Department of Surgery, Drexel University College of Medicine, Philadelphia, PA, USA;4. Department of Pharmacology and Physiology, Drexel University College of Medicine, Philadelphia, PA, USA;5. Department of Neurology, Agnes Ginges Center for Human Neurogenetics, Hadassah-Hebrew University Medical Center, Jerusalem, Israel;6. Department of Radiology, Children''s Hospital of Philadelphia, University of Pennsylvania School of Medicine, Philadelphia, PA, USA;7. Department of Radiology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel;8. The David R. Bloom Centre for Pharmacy and Dr. Adolf and Klara Brettler Centre for Research in Molecular Pharmacology and Therapeutics, The Hebrew University of Jerusalem, Jerusalem, Israel |
| |
| Abstract: | The consideration of epilepsy surgery for those with medically refractory seizure disorders requires a well-functioning multidisciplinary team and a systematic approach to investigations, with the aim of advising patients of their chances of being seizure free following surgery, and the risks of any procedure. Investigatory pathways may be outlined that cover most clinical situations, and the indications for invasive EEG studies. It is crucial that patients and their families are given realistic expectations of what may, and may not, be achieved with surgical treatment, and that long-term follow-up is maintained post-operatively. |
| |
| Keywords: | |
| 本文献已被 ScienceDirect 等数据库收录！ |
|
